August Bioservices - End to End (Preclinical to Clinical to Commercial), US-based CDMO Capabilities

This is an overview capabilities brochure of the services and expertise August Bioservices offers to biotech and pharma companies of all sizes. As a growing, US-based provider of expert CDMO services, August is rapidly becoming a preferred partner for clients seeking deep drug development, formulation, scale-up, testing and manufacturing expertise, a breadth of capabilities to support activities all along the drug commercialization pathway, and decades of experience successfully bringing finished drug products to market.www.augustbio.com www.augustbiospecializedservices.com